We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants

Delisted

COEPW was delisted on the 24th of April, 2026.

13 hedge funds and large institutions have $21.4K invested in Coeptis Therapeutics Warrants in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.97% less ownership

Funds ownership: 4.47%2.5% (-2%)

22% less capital invested

Capital invested by funds: $27.4K → $21.4K (-$6.05K)

24% less funds holding

Funds holding: 1713 (-4)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
13
Holders Change
-4
Holders Change %
-23.53%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
4
Closed
4
Calls
Puts
Net Calls
Net Calls Change

COEPW Hedge Fund Activity: Q4 2024 in Review

13 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q4 2024, worth a combined $21.4K — down 22% from $27.4K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of COEPW and 0 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 3 added.

The largest buyer was Walleye Trading, adding an estimated $1.47K. The largest seller was Meteora Capital, cutting an estimated $14K.

  • 13 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q4 2024, down from 17 in Q3 2024.
  • Funds reported $21.4K of Coeptis Therapeutics Warrants stock for Q4 2024, down 22% quarter-over-quarter.
  • 0 funds opened new Coeptis Therapeutics Warrants positions in Q4 2024 and 4 closed out, a net change of -4 holders.
  • The largest Coeptis Therapeutics Warrants buyer in Q4 2024 was Walleye Trading, an estimated $1.47K added.
  • The largest Coeptis Therapeutics Warrants seller in Q4 2024 was Meteora Capital, an estimated $14K sold.

Based on aggregated 13F filings for Q4 2024.